Affiliation:
1. Almazov National Medical Research Centre
Abstract
Introduction. The problem of early detection of pulmonary arterial hypertension (PAH) is closely related to the diagnosis of systemic sclerosis (SSc). It is especially important in patients with slight manifestations of the disease, making it diffcult to verify the diagnosis before the clinic of right ventricular heart failure, and low knowledge of the general practitioners of the available diagnostic opportunities.The aim of the work was to identify the earliest clinical signs of PAH associated with SSc for its early diagnosis.Material and methods. The study included 51 patients with limited SSc. The investigators evaluated the extent of skin lesion, levels of the level of Nterminal brain natriureticpropeptide (NTproBNP) and uric acid, the fluorescent pattern and titer of antinuclear factor. All patients underwent an echocardiography, nailfold videocapillaroscopy, a comprehensive assessment of external respiratory functions. When there were symptoms of PAH, right heart catheterization was performed to confrm it.Results. PAH was detected in 19 of the 51 patients included in the study. Patients with PAH were signifcantly older than those without PAH: (60±8) and (54±7) years, respectively (p=0.02); there were also differences between these groups in the signs of right cardiac remodeling (p<0.05), in the indices estimated in the sixminute walk test (p<0.05), in the assessment of lung diffusing capacity (p<0.001), in levels of NTproBNP and uric acid (p<0.001), in the density of the nailfold capillaries (p=0.009); in a semiquantitative assessment of nailfold capillary alterations (p=0.022). Among patients with PAH associated with SSc, seven patients were diagnosed with SSc for the frst time after referring to cardiologists and verifying the genesis of PAH, while other 12 patients were previously observed by rheumatologists. Differences in the duration of the period from the onset of symptoms to the diagnosis of SSc (p=0.043) were revealed between these groups.Conclusion. The study shows the probability of the presence of SSc in patients with suspected idiopathic PAH, that determines the necessity of additional immunological and instrumental examinations in such patients.
Publisher
FSBEI HE I.P. Pavlov SPbSMU MOH Russia
Reference15 articles.
1. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, 2015. Doi: 10.1093/eurheartj/ehv317.
2. Hachulla E, Carpentier P, Gressin V. Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study. Rheumatology (Oxford). 2009;48(3):304–308. Doi: 10.1093/rheumatology/ken488a.
3. Cavagna L, Codullo V, Ghio S, Scire CA, Guzzafame E, Scelsi L, Rossi S, Montecucco C, Caporali R. Undiagnosed connective tissue diseases. High prevalence in pulmonary arterial hypertension patients. Medicine. 2016;95:39(e4827). Doi: 10.1097/md.0000000000004827.
4. Ahmed S, Palevsky H. Pulmonary Arterial Hypertension Related to Connective Tissue Disease: A Review.Rheum Dis Clin North Am. 2014;40(1):103–124. Doi: 10.1016/j.rdc.2013.10.001.
5. Le Pavec J, Humbert M, Mouthon L. Systemic Sclerosisassociated Pulmonary Arterial Hypertension. Am J RespirCrit Care Med. 2010;181(12):1285–1293. Doi: 10.1164/rccm.200909-1331pp.